ProstaCard: Developing Novel Interactive Tools for Patient Education and Decision-Making in Benign Prostatic Hyperplasia Management
DOI:
https://doi.org/10.29303/jk.v14i1.5960Keywords:
Interactive Tools, Benign Prostate Hyperplasia, Education, Decision-MakingAbstract
Introduction: Benign Prostatic Hyperplasia (BPH) presents significant challenges for patient comprehension and decision-making due to its intricate nature and the multitude of available treatment options. Educational interventions are increasingly acknowledged as effective means of addressing these challenges. This study focused on the development and assessment of ‘ProstaCard’, an interactive educational tool designed to enhance patient understanding of BPH and support informed decision-making in its management. Methods: The development of the tool involved a collaborative effort among urologists, game designers, and educators. The prototype was iteratively refined through an analysis of patient needs and feedback from healthcare professionals. To evaluate the tool’s efficacy in enhancing patient knowledge and decision-making skills, a preliminary pre-test/post-test design was utilized. Both quantitative and qualitative data were gathered from patients and healthcare providers to assess the tool's impact. Discussion: The results demonstrate that ‘ProstaCard’ substantially enhanced patients' understanding of BPH and their capacity to make informed decisions regarding treatment options. The tool successfully engaged participants in the educational process and facilitated dialogue between patients and healthcare providers. Nevertheless, additional research is required to investigate the long-term impact of the tool on patient outcomes and its potential integration into clinical practice. ‘ProstaCard’ shows potential as a novel educational tool for enhancing patient understanding and decision-making in the management of BPH. By offering an interactive and informative platform, the tool enables patients to engage more actively in their care, which may lead to improved treatment outcomes. Ongoing development and assessment of the tool are crucial to maximizing its effectiveness and applicability in clinical environments.
Downloads
Published
2025-03-30
Issue
Section
Articles
License
Authors who publish with Unram Medical Journal, agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, websites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in University of Mataram's Journal of Medicine.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- This journal is open access journal which means that all content is freely available without charge to users or / institution. Users are allowed to read, download, copy, distribute, print, search, or link to full text articles in this journal without asking prior permission from the publisher or author.
